Oxidative Stress in Chronic Obstructive Pulmonary Disease

Paul Kirkham; Peter J Barnes

doi:10.1201/b16653-18

Abstract

1 min read

Fatty liver disease (FLD) consists of alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD), with a subset of these groups developing alcoholic steatohepatitis (ASH) and nonalcoholic steatohepatitis (NASH), respectively (Adams et al. 2005, Browning et al. 2004b, Hamaguchi et al. 2005).

Related publications

Article2019

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)

Hannah K. Drescher, Sabine Weiskirchen, Ralf Weiskirchen

Article2014

Clinical Features of Pediatric Nonalcoholic Fatty Liver Disease

R. Constance Wiener, Peter J Barnes, Matthew J. Gurka, Mark D. DeBoer, Jeremy P. Middleton

Article2021

From Liver Fat to Cancer: Perils of the Western Diet

Ju Youn Kim, Feng He, Michael Karin

Article2020

Deletion of Perilipin 5 Protects against Hepatic Injury in Nonalcoholic Fatty Liver Disease via Missing Inflammasome Activation

Anastasia Asimakopoulou, Kathrin M. Engel, Nikolaus Gaßler, Thilo Bracht, Barbara Sitek, Eva Miriam Buhl, Stavroula Kalampoka, Manuela Pinoé-Schmidt, Josef van Helden, Jürgen Schiller, Ralf Weiskirchen

Preprint2021

Efficacy of Lenvatinib for Unresectable Hepatocellular Carcinoma Based on Background Liver Disease Etiology: Multi-center Retrospective Study

Atsushi Hiraoka, Takashi Kumada, Toshifumi Tada, Joji Tani, Kazuya Kariyama, Shinya Fukunishi, Masanori Atsukawa, Masashi Hirooka, Kunihiko Tsuji, Toru Ishikawa, Koichi Takaguchi, Ei Itobayashi, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Kazuhito Kawata, Satoshi Yasuda, Hidenori Toyoda, Tomoko Aoki, Takaaki Tanaka, Hideko Ohama, Kazuhiro Nouso,